NASDAQ:MDVN (MDVN) (MDVN) Stock Price, News & Analysis → A lot of people are making this costly mistake (From WealthPress) (Ad) Free MDVN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$81.44▼$81.4450-Day Range N/A52-Week Range$26.41▼$81.48VolumeN/AAverage Volume3.55 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (MDVN) alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About (MDVN) Stock (NASDAQ:MDVN)Medivation, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to treat serious diseases for which there are limited treatment options. The Company, in collaboration with Astellas Pharma, Inc. (Astellas), has one commercial product, XTANDI (enzalutamide) capsules (XTANDI). XTANDI has received marketing approval in the United States, Europe and other countries across the world for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) and in Japan for the treatment of patients with castration-resistant prostate cancer (CRPC). The Company, in collaboration with Astellas, is also conducting investigational studies of enzalutamide in prostate cancer and in advanced breast cancer. It has developed a small molecule inhibitor of the sterol regulatory element-binding protein, or SREBP, pathway which it refers to as MDV4463.Read More Ad DTIthe most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.And you can see how it works for FREE when you Click Here MDVN Stock News HeadlinesMarch 27, 2024 | nasdaq.comNotable ETF Outflow Detected - HYLBJanuary 28, 2024 | msn.comNearly a thousand take chilly plunge off Oak Street Beach for annual fundraiserMarch 29, 2024 | Crypto 101 Media (Ad)Major Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.January 8, 2024 | msn.comPackers beat Bears 17-9 to clinch playoff spot, head to DallasDecember 30, 2023 | msn.comGoogle agrees to settle $5-B lawsuit over ‘incognito’ modeDecember 29, 2023 | msn.comKanye West and Wife Bianca Censori Will Have a 'Fiery' Start to 2024, Psychic PredictsSeptember 2, 2023 | thestreet.comMedivation Alzheimer's Drug Fails Pivotal StudyJune 26, 2023 | thestreet.comMedivation (MDVN) Stock Falling After Earnings Estimates CutMarch 29, 2024 | Crypto Swap Profits (Ad)Grab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.June 26, 2023 | thestreet.comMedivation (MDVN) Stock Falling After Earnings Estimates CutJune 13, 2023 | morningstar.comCore Medalist ETFsMay 31, 2023 | bbc.co.ukThe Connor Phillips ShowApril 21, 2023 | thestreet.comIncyte (INCY) Stock Rises on Takeover Speculation After $14 Billion Pfizer, Medivation DealApril 21, 2023 | thestreet.comMedivation Stock Hits New 52-Week High (MDVN)April 1, 2023 | msn.comMavs Lose to Heat, Play-In Hopes Continue to Take Major HitsMarch 8, 2023 | msn.comMillie Bobby Brown is 'ready to leave Stranger ThingsJanuary 26, 2023 | msn.comLake Nacogdoches notches its first 2023 Legacy ShareLunkerJanuary 15, 2023 | msn.comEx-Huddersfield Town boss Danny Cowley pens emotional goodbye message to Portsmouth supportersDecember 29, 2022 | msn.comGoody’s Name Creates Another Addams Family Wednesday MysteryDecember 25, 2022 | thestreet.comMedivation (MDVN) Stock Surges, Will Explore SaleOctober 18, 2022 | finance.yahoo.comJupiter Wellness’s Potential New OTC Drug Could Put Some More Joy Back Into Breast Cancer Survivors’ Lives - Yahoo FinanceOctober 10, 2022 | msn.comNBC played the 'That’s So Raven' theme and people are freaking out about it: Best memes & tweetsOctober 7, 2022 | marketscreener.comPortage Biotech : NOTICE OF ANNUAL GENERAL MEETING - Form 6-K - Marketscreener.comAugust 5, 2022 | msn.comThe Impressions star Sam Gooden dies aged 87July 16, 2022 | thestreet.comCramer's Top Stock Picks: BMY NDLS NFLX MDVN SGEN BMRNMay 31, 2022 | thestreet.comThe 5 Dumbest Things on Wall Street This Week: Aug. 3March 24, 2022 | benzinga.comOption Alert: MDVN 4,950 Jul $65 Call @Bid @$0.30 - Benzinga - BenzingaSee More Headlines Receive MDVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (MDVN) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/09/2016Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryBiotechnology Current SymbolNASDAQ:MDVN CUSIP58501N10 CIK1011835 Webwww.medivation.com Phone+1-415-5433470FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report MDVN Stock Analysis - Frequently Asked Questions How were (MDVN)'s earnings last quarter? (MDVN) (NASDAQ:MDVN) announced its quarterly earnings data on Tuesday, August, 9th. The biopharmaceutical company reported $0.29 EPS for the quarter, beating analysts' consensus estimates of $0.27 by $0.02. The biopharmaceutical company earned $206 million during the quarter, compared to analysts' expectations of $214.52 million. The company's revenue for the quarter was up 17.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.58 earnings per share. What other stocks do shareholders of (MDVN) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (MDVN) investors own include Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), Incyte (INCY), First Solar (FSLR), United Airlines (UAL), Dynavax Technologies (DVAX), (KITE) (KITE), Array Technologies (ARRY), Freeport-McMoRan (FCX) and This page (NASDAQ:MDVN) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (MDVN) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.